Position in PFE
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,990,212
+$1,769,474 QoQ
Shares Held
82,650
+832.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#966
of 2,821 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sivia Capital Partners, LLC holds $16,248,994 across 14 Drug Manufacturers - General names. PFE ranks #4 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,555 | $4,263,974 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
47,373 | $2,729,632 | |
| 3 | MRK |
Merck & Co., Inc.
|
16,440 | $2,112,540 | |
| 4 | PFE |
Pfizer Inc
This page
|
82,650 | $1,990,212 | |
| 5 | NVS |
Novartis AG
|
6,151 | $963,984 | |
| 6 | JNJ |
Johnson & Johnson
|
3,459 | $878,482 | |
| 7 | BIIB |
Biogen Inc.
|
3,879 | $838,096 | |
| 8 | GSK |
GSK plc
|
10,340 | $542,022 |
All Filings in PFE
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,990,212 | 82,650 | Shares | Sole | 2026-07-23 | |
| 2025-12-31 | $220,738 | 8,865 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $243,894 | 9,572 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $207,567 | 8,563 | Shares | Sole | 2025-09-24 | |
| 2025-03-31 | $370,572 | 14,624 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $274,665 | 10,353 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $354,080 | 12,235 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $346,252 | 12,375 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $281,801 | 10,155 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $287,151 | 9,974 | Shares | Sole | 2024-03-13 | |
| No filing history on record for this holder in this stock. | ||||||